Prevalence and Prognosis of Cardiac Amiloidosis in Turkey

NCT04915235 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2087

Last updated 2021-06-07

No results posted yet for this study

Summary

Patients with left ventricular hypertrophy are further examined according to an algorithm to check if they have a cardiac amyloidosis

Conditions

  • Cardiac Amyloidosis

Interventions

BEHAVIORAL

Algorithm

Algorithm

Sponsors & Collaborators

  • Turkish Society of Cardiology

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-18
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04915235 on ClinicalTrials.gov